CD8A and cancer: OX40 is a ligand-activated T-cell co-stimulator that mediates the survival and expansion of CD4+ and CD8+ T cells in a variety of animal models of autoimmunity, infectious disease, and cancer, and is also involved in the control of effector and memory T-cell responses.